Fundraising Fox

Iridia

5 known investors

Iridia develops Molecular Avatar Technology that embeds unalterable molecular identities and custom data (text, image, audio, or video) into physical products and materials such as paints, coatings, plastics, and liquids. The technology is aimed at brands seeking product authentication, traceability, and anti-counterfeiting without changing a product's appearance or function.

Investors · 5

Competitors · 4

by search overlap

Companies competing with Iridia for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2022$255K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Frequently asked questions

What does Iridia do?
Iridia develops Molecular Avatar Technology that embeds unalterable molecular identities and custom data (text, image, audio, or video) into physical products and materials such as paints, coatings, plastics, and liquids. The technology is aimed at brands seeking product authentication, traceability, and anti-counterfeiting without changing a product's appearance or function.
Who are Iridia's investors?
Iridia's investors include Connecticut Innovations, Duke Capital Partners, Longley Capital, LifeSci Venture Partners, Prime Movers Lab.